Graham Johnson
Directeur/Membre du Conseil chez Shimoda Resources Holdings, Inc.
Profil
Graham Johnson is currently a Director at Shimoda Resources Holdings, Inc. He previously worked as an Interim Vice President-Neuroscience Biology at Bristol Myers Squibb Co. and held the position of Senior VP-Preclinical Development & Research at Sarepta Therapeutics, Inc. from 2010 to 2011.
He also worked as a Principal at Parke-Davis & Co. Ltd.
and as the Chief Research Officer at Melinta Subsidiary Corp.
Dr. Johnson received his undergraduate and doctorate degrees from Heriot-Watt University.
Postes actifs de Graham Johnson
| Sociétés | Poste | Début |
|---|---|---|
Shimoda Resources Holdings, Inc.
 Shimoda Resources Holdings, Inc. Investment Trusts/Mutual FundsMiscellaneous Shimoda Resources Holdings, Inc. operates as a investment holding company in natural resources sector. The company is headquartered in Wilton, CT. | Directeur/Membre du Conseil | - |
Anciens postes connus de Graham Johnson
| Sociétés | Poste | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 13/05/2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Corporate Officer/Principal | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Directeur Technique/Scientifique/R&D | - |
Formation de Graham Johnson
| Heriot-Watt University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Shimoda Resources Holdings, Inc.
Shimoda Resources Holdings, Inc. Investment Trusts/Mutual FundsMiscellaneous Shimoda Resources Holdings, Inc. operates as a investment holding company in natural resources sector. The company is headquartered in Wilton, CT. | Miscellaneous |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |